As one of the leading health research institutes in Canada, Lawson has many stories to tell. Search through our Latest News to find out about important medical breakthroughs, major announcements and research publications, new clinical trials, industry partnerships, commercialization developments and more.
Our Events calendar includes a variety of research, industry and foundation listings You can also find out more about Lawson’s signature events:
Hospital-based research is uniquely positioned to tackle the unprecedented COVID-19 challenge and quickly translate results into illness prevention and care for patients. Lawson Health Research Institute, the research institute of London Health Sciences Centre (LHSC) and St. Joseph’s Health Care London, has awarded more than $202,000 to its research teams to support critical discoveries during the pandemic.
As part of an initiative called the Global Consortium for Chemosensory Research (GCCR), scientists at Lawson Health Research Institute and Western University are studying the sudden loss of smell in COVID-19 patients. They are asking individuals with confirmed or presumptive cases of COVID-19 worldwide to participate in a survey to better understand this symptom.
Lung cancer is the most commonly diagnosed cancer in Canada. While the standard treatment for patients with early-stage lung cancer is surgery, up to half of these patients may develop a recurrence after their treatment.
Jaryd Christie is a Master’s candidate working with Lawson Scientist, Dr. Sarah Mattonen. Together, they are working to develop a new software that uses artificial intelligence (AI) to identify which patients are likely to have recurring cancer.